Michael Mensinger
Net worth: 2 M $ as of 30/05/2026
Net worth: 2 M $ as of 30/05/2026
Mr. Michael R.
Mensinger is a Chief Product Officer at Beta Bionics, Inc. Mr. Mensinger was previously employed as a Chief Technology Officer by Companion Medical, Inc. and an Engineering Manager by DexCom, Inc. He received his undergraduate degree from the University of Delaware.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BETA BIONICS, INC. 0.41% | 01/06/2026 | 184,415 ( 0.41% ) | 2 M $ | 30/05/2026 |
BETA BIONICS, INC. -.--% | 28/01/2025 | 0 ( -.--% ) | - $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| BETA BIONICS, INC. | Corporate Officer/Principal | 31/07/2023 |
| Companies | Position | End |
|---|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Chief Tech/Sci/R&D Officer | 31/07/2023 |
| DEXCOM, INC. | Corporate Officer/Principal | 31/03/2017 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Health Technology |
DexCom, Inc.
DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
Select your edition
All financial news and data tailored to specific country editions